Abstract 536: Insulin-like growth factor II (IGF-II) is a potential target for the treatment of triple negative breast cancers (TNBC)

• Published in: Cancer research (Chicago, Ill.) Vol. 73; no. 8_Supplement; p. 536
• Main Authors: Radhakrishnan, Vinodh Kumar, Tan, Qianwei, De León, Marino A., De León, Daisy D.
• Format: Journal Article
• Language: English
• Published: 15.04.2013

Abstract In the United States, African American (AA) women have a lower incidence of breast cancer compared to Caucasian (CA) women, but higher overall mortality. Our lab have demonstrated that Breast Cancer from AA patients express significantly higher levels of IGF-II and show a higher activation...